Copyright Reports & Markets. All rights reserved.

Global Synthetic Blood Substitutes Market Research Report 2021

Request for Sample of this report
Buy now

1 Synthetic Blood Substitutes Market Overview

  • 1.1 Product Overview and Scope of Synthetic Blood Substitutes
  • 1.2 Synthetic Blood Substitutes Segment by Product Type
    • 1.2.1 Global Synthetic Blood Substitutes Sales Growth Rate Comparison by Product Type (2021-2027)
    • 1.2.2 Hemoglobin-Based Oxygen Carriers (HBOCs)
    • 1.2.3 Perfluorocarbon (PFCs)
    • 1.2.4 Others
  • 1.3 Synthetic Blood Substitutes Segment by Application
    • 1.3.1 Synthetic Blood Substitutes Sales Comparison by Application: (2021-2027)
    • 1.3.2 Cardiovascular Diseases
    • 1.3.3 Anemia
    • 1.3.4 Malignant Neoplasm
    • 1.3.5 Injuries and Trauma
    • 1.3.6 Neonatal Conditions
    • 1.3.7 Maternal Conditions
    • 1.3.8 Organ Transplant
    • 1.3.9 Others
  • 1.4 Global Synthetic Blood Substitutes Market Size Estimates and Forecasts
    • 1.4.1 Global Synthetic Blood Substitutes Revenue 2016-2027
    • 1.4.2 Global Synthetic Blood Substitutes Sales 2016-2027
    • 1.4.3 Synthetic Blood Substitutes Market Size by Region: 2016 Versus 2021 Versus 2027

2 Synthetic Blood Substitutes Market Competition by Manufacturers

  • 2.1 Global Synthetic Blood Substitutes Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Synthetic Blood Substitutes Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Synthetic Blood Substitutes Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Synthetic Blood Substitutes Manufacturing Sites, Area Served, Product Type
  • 2.5 Synthetic Blood Substitutes Market Competitive Situation and Trends
    • 2.5.1 Synthetic Blood Substitutes Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Synthetic Blood Substitutes Players Market Share by Revenue
    • 2.5.3 Global Synthetic Blood Substitutes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Synthetic Blood Substitutes Retrospective Market Scenario by Region

  • 3.1 Global Synthetic Blood Substitutes Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Synthetic Blood Substitutes Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Synthetic Blood Substitutes Market Facts & Figures by Country
    • 3.3.1 North America Synthetic Blood Substitutes Sales by Country
    • 3.3.2 North America Synthetic Blood Substitutes Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Synthetic Blood Substitutes Market Facts & Figures by Country
    • 3.4.1 Europe Synthetic Blood Substitutes Sales by Country
    • 3.4.2 Europe Synthetic Blood Substitutes Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Synthetic Blood Substitutes Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Synthetic Blood Substitutes Sales by Region
    • 3.5.2 Asia Pacific Synthetic Blood Substitutes Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Synthetic Blood Substitutes Market Facts & Figures by Country
    • 3.6.1 Latin America Synthetic Blood Substitutes Sales by Country
    • 3.6.2 Latin America Synthetic Blood Substitutes Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Synthetic Blood Substitutes Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Synthetic Blood Substitutes Sales by Country
    • 3.7.2 Middle East and Africa Synthetic Blood Substitutes Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Synthetic Blood Substitutes Historic Market Analysis by Type

  • 4.1 Global Synthetic Blood Substitutes Sales Market Share by Type (2016-2021)
  • 4.2 Global Synthetic Blood Substitutes Revenue Market Share by Type (2016-2021)
  • 4.3 Global Synthetic Blood Substitutes Price by Type (2016-2021)

5 Global Synthetic Blood Substitutes Historic Market Analysis by Application

  • 5.1 Global Synthetic Blood Substitutes Sales Market Share by Application (2016-2021)
  • 5.2 Global Synthetic Blood Substitutes Revenue Market Share by Application (2016-2021)
  • 5.3 Global Synthetic Blood Substitutes Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Hemarina
    • 6.1.1 Hemarina Corporation Information
    • 6.1.2 Hemarina Description and Business Overview
    • 6.1.3 Hemarina Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Hemarina Product Portfolio
    • 6.1.5 Hemarina Recent Developments/Updates
  • 6.2 Sagart Corporation
    • 6.2.1 Sagart Corporation Corporation Information
    • 6.2.2 Sagart Corporation Description and Business Overview
    • 6.2.3 Sagart Corporation Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sagart Corporation Product Portfolio
    • 6.2.5 Sagart Corporation Recent Developments/Updates
  • 6.3 FLUORO2 Therapeutics
    • 6.3.1 FLUORO2 Therapeutics Corporation Information
    • 6.3.2 FLUORO2 Therapeutics Description and Business Overview
    • 6.3.3 FLUORO2 Therapeutics Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 FLUORO2 Therapeutics Product Portfolio
    • 6.3.5 FLUORO2 Therapeutics Recent Developments/Updates
  • 6.4 Biopure Corporation
    • 6.4.1 Biopure Corporation Corporation Information
    • 6.4.2 Biopure Corporation Description and Business Overview
    • 6.4.3 Biopure Corporation Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Biopure Corporation Product Portfolio
    • 6.4.5 Biopure Corporation Recent Developments/Updates
  • 6.5 Alpha Therapeutic Corporation
    • 6.5.1 Alpha Therapeutic Corporation Corporation Information
    • 6.5.2 Alpha Therapeutic Corporation Description and Business Overview
    • 6.5.3 Alpha Therapeutic Corporation Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Alpha Therapeutic Corporation Product Portfolio
    • 6.5.5 Alpha Therapeutic Corporation Recent Developments/Updates
  • 6.6 KaloCyte
    • 6.6.1 KaloCyte Corporation Information
    • 6.6.2 KaloCyte Description and Business Overview
    • 6.6.3 KaloCyte Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 KaloCyte Product Portfolio
    • 6.6.5 KaloCyte Recent Developments/Updates
  • 6.7 Baxter
    • 6.6.1 Baxter Corporation Information
    • 6.6.2 Baxter Description and Business Overview
    • 6.6.3 Baxter Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Baxter Product Portfolio
    • 6.7.5 Baxter Recent Developments/Updates
  • 6.8 Green Cross Corporation
    • 6.8.1 Green Cross Corporation Corporation Information
    • 6.8.2 Green Cross Corporation Description and Business Overview
    • 6.8.3 Green Cross Corporation Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Green Cross Corporation Product Portfolio
    • 6.8.5 Green Cross Corporation Recent Developments/Updates
  • 6.9 North Field Laboratories
    • 6.9.1 North Field Laboratories Corporation Information
    • 6.9.2 North Field Laboratories Description and Business Overview
    • 6.9.3 North Field Laboratories Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 North Field Laboratories Product Portfolio
    • 6.9.5 North Field Laboratories Recent Developments/Updates
  • 6.10 Alliance Pharmaceutical Corporation
    • 6.10.1 Alliance Pharmaceutical Corporation Corporation Information
    • 6.10.2 Alliance Pharmaceutical Corporation Description and Business Overview
    • 6.10.3 Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Alliance Pharmaceutical Corporation Product Portfolio
    • 6.10.5 Alliance Pharmaceutical Corporation Recent Developments/Updates

7 Synthetic Blood Substitutes Manufacturing Cost Analysis

  • 7.1 Synthetic Blood Substitutes Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Synthetic Blood Substitutes
  • 7.4 Synthetic Blood Substitutes Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Synthetic Blood Substitutes Distributors List
  • 8.3 Synthetic Blood Substitutes Customers

9 Synthetic Blood Substitutes Market Dynamics

  • 9.1 Synthetic Blood Substitutes Industry Trends
  • 9.2 Synthetic Blood Substitutes Growth Drivers
  • 9.3 Synthetic Blood Substitutes Market Challenges
  • 9.4 Synthetic Blood Substitutes Market Restraints

10 Global Market Forecast

  • 10.1 Synthetic Blood Substitutes Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Synthetic Blood Substitutes by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Synthetic Blood Substitutes by Type (2022-2027)
  • 10.2 Synthetic Blood Substitutes Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Synthetic Blood Substitutes by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Synthetic Blood Substitutes by Application (2022-2027)
  • 10.3 Synthetic Blood Substitutes Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Synthetic Blood Substitutes by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Synthetic Blood Substitutes by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    by Product Type
    Hemoglobin-Based Oxygen Carriers (HBOCs)
    Perfluorocarbon (PFCs)
    Others
    by Source
    Human Blood
    Animal Blood
    Microorganisms
    Synthetic Polymers
    Stem Cells
    Others

    Segment by Application
    Cardiovascular Diseases
    Anemia
    Malignant Neoplasm
    Injuries and Trauma
    Neonatal Conditions
    Maternal Conditions
    Organ Transplant
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Hemarina
    Sagart Corporation
    FLUORO2 Therapeutics
    Biopure Corporation
    Alpha Therapeutic Corporation
    KaloCyte
    Baxter
    Green Cross Corporation
    North Field Laboratories
    Alliance Pharmaceutical Corporation

    Buy now